- funded by IMI-JU
- 01 March 2011 - 31 August 2016
- 11 EFPIA members
- 10 Academia and 5 SME's
- Total cost € 23,032,609
Cyprotex is a world-renowned SME focussed on the provision of in vitro and in silico services and products in ADME (Absorption, Distribution, Metabolism and Elimination), pharmacokinetics and toxicity to the pharmaceutical and agrochemical industries.
Domains of expertise include development of physiologically-based pharmacokinetic (PBPK) and other models; automation of modelling and data-processing workflows; integration of in vitro and in vivo data in predictive modelling. We bring extensive knowledge of PBPK modelling in drug discovery and development, and workflow automation in many modelling and data-processing tasks, backed up by a high level of software engineering expertise.